Abstract
Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab′) 2-mediated anti-complement activity : Latremouille CH, Genevaz D, Hu MC, et al. Clin Exp Immunol 110:122–126, 1997
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
